NAD+/MOTS-C/5-Amino-1MQ, also called Mitoprime, is a three-peptide blend containing NAD+ (100mg), MOTS-C (10mg), and 5-Amino-1MQ (10mg) in a single 120mg lyophilized vial
For more information, contact us today to schedule a consultation online
Liraglutide, another GLP-1 receptor agonist with a longer track record than semaglutide, has not generated significant reports of b12 deficiency in clinical practice
By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon secretion, and slows gastric emptying
For semaglutide, discontinuation at least 2 months before a planned pregnancy is recommended due to its long half-life